We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 21, 2020

TTC-352 in Patients With MBC Progressing on Endocrine and CDK4/6 Inhibitor Therapy

Breast Cancer Research and Treatment

 

Additional Info

Breast Cancer Research and Treatment
Phase 1 Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine and CDK4/6 Inhibitor Therapy
Breast Cancer Res Treat 2020 Jul 22;183(xx)617-627, AZ Dudek, LC Liu, JH Fischer, EL Wiley, JC Sachdev, J Bleeker, RW Hurley, DA Tonetti, GRJ Thatcher, RP Venuti, RM O'Regan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading